XML 20 R8.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Oct. 09, 2021
Oct. 03, 2020
Cash flows from operating activities    
Net earnings $ 51,506 $ 63,821
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Non-cash restructuring, asset impairment, and other charges 3,075 18,780
Depreciation and amortization 71,260 68,984
Non-cash rent (2,923) (4,720)
LIFO expense 10,444 3,158
Postretirement benefits expense 1,795 1,216
Deferred income taxes 7,970 (2,084)
Stock-based compensation expense 5,977 5,279
Stock warrant 1,478  
(Gain) loss on disposals of assets (213) 3,403
Other operating activities 946 1,133
Changes in operating assets and liabilities:    
Accounts receivable (14,295) (42,832)
Inventories (19,268) (52,578)
Prepaid expenses and other assets (18,183) (7,268)
Accounts payable 37,939 116,075
Accrued payroll and benefits (13,920) 46,262
Current income taxes 19,262 1,801
Other accrued expenses and other liabilities 1,103 3,402
Net cash provided by operating activities 143,953 223,832
Cash flows from investing activities    
Purchases of property and equipment (54,957) (45,880)
Net proceeds from the sale of assets 29,171 9,111
Loans to customers (180) (992)
Payments from customers on loans 1,939 2,237
Other investing activities (24) (12)
Net cash used in investing activities (24,051) (35,536)
Cash flows from financing activities    
Proceeds from senior secured credit facility 1,047,051 989,897
Payments on senior secured credit facility (1,128,522) (1,131,187)
Repayment of other long-term debt and finance lease liabilities (4,511) (5,043)
Share repurchases (5,325) (10,000)
Net payments related to stock-based award activities (2,253) (1,389)
Dividends paid (21,344) (27,636)
Other financing activities (256) (207)
Net cash used in financing activities (115,160) (185,565)
Net increase in cash and cash equivalents 4,742 2,731
Cash and cash equivalents at beginning of period 19,903 24,172
Cash and cash equivalents at end of period $ 24,645 $ 26,903